Oncolytic adenovirus programmed by synthetic gene circuit for cancer immunotherapy
It is difficult to improve the efficacy of oncolytic virotherapy due to immune system responses and limited understanding of population dynamics. Here the authors use synthetic biology gene circuits to control adenoviral replication and release of immunomodulators in hepatocellular carcinoma cells.
Guardado en:
Autores principales: | Huiya Huang, Yiqi Liu, Weixi Liao, Yubing Cao, Qiang Liu, Yakun Guo, Yinying Lu, Zhen Xie |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d02993ca48bb47c3813974088403a7cc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Systemic therapy for cervical cancer with potentially regulatable oncolytic adenoviruses.
por: Anna Kanerva, et al.
Publicado: (2008) -
Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy
por: Masmudur M. Rahman, et al.
Publicado: (2021) -
A potential bat adenovirus-based oncolytic virus targeting canine cancers
por: Hiromichi Matsugo, et al.
Publicado: (2021) -
Anti-tumor activity of a miR-199-dependent oncolytic adenovirus.
por: Elisa Callegari, et al.
Publicado: (2013) -
Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus.
por: Laura Ahtiainen, et al.
Publicado: (2010)